99 related articles for article (PubMed ID: 17392711)
1. Hormone receptors in defining breast cancer prognosis--time for a rethink?
Speirs V; Shaaban AM
Nat Clin Pract Oncol; 2007 Apr; 4(4):204-5. PubMed ID: 17392711
[No Abstract] [Full Text] [Related]
2. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with estrogen receptors-alpha (ER-alpha) and -beta (ER-beta) and progesterone receptor abundance in obese and non obese pre- and post-menopausal women.
Meza-Muñoz DE; Fajardo ME; Pérez-Luque EL; Malacara JM
Steroids; 2006 Jun; 71(6):498-503. PubMed ID: 16566954
[TBL] [Abstract][Full Text] [Related]
4. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G
J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459
[TBL] [Abstract][Full Text] [Related]
5. The estrogen receptors alpha, beta, and beta cx.
Shaaban AM; Speirs V
Clin Cancer Res; 2005 Nov; 11(22):8222; author reply 8222-3. PubMed ID: 16299256
[No Abstract] [Full Text] [Related]
6. Estrogen receptor-beta status influences clinical outcome of triple-negative breast cancer.
Sakamoto G; Honma N
Breast Cancer; 2009; 16(4):281-2. PubMed ID: 19387776
[TBL] [Abstract][Full Text] [Related]
7. [The role of definition of receptor status in the prognosis and the choice of adequate treatment tactics of breast tumors].
Abuladze TZ; Nemsadze GG; Gersamiia GK
Georgian Med News; 2006 Aug; (137):22-4. PubMed ID: 16980736
[No Abstract] [Full Text] [Related]
8. GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival.
Engelsen IB; Stefansson IM; Akslen LA; Salvesen HB
Am J Obstet Gynecol; 2008 Nov; 199(5):543.e1-7. PubMed ID: 18599012
[TBL] [Abstract][Full Text] [Related]
9. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
[TBL] [Abstract][Full Text] [Related]
10. Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
Yang XR; Pfeiffer RM; Garcia-Closas M; Rimm DL; Lissowska J; Brinton LA; Peplonska B; Hewitt SM; Cartun RW; Mandich D; Sasano H; Evans DB; Sutter TR; Sherman ME
Cancer Res; 2007 Nov; 67(21):10608-17. PubMed ID: 17968031
[TBL] [Abstract][Full Text] [Related]
11. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha to beta ratio: a counterpart also in adrenal cortical neoplasia?
Georgiadou D; Sergentanis TN; Papastratis G
Med Hypotheses; 2008; 70(6):1225. PubMed ID: 18226862
[No Abstract] [Full Text] [Related]
13. Time for reappraisal of progesterone-receptor testing in breast cancer management.
MacGrogan G; de Mascarel I; Sierankowski G; Mauriac L; Debled M; Durand M; De Lara CT; Avril A; Picot V; Mathoulin-Pélissier S
J Clin Oncol; 2005 Apr; 23(12):2870-1; author reply 2871. PubMed ID: 15838009
[No Abstract] [Full Text] [Related]
14. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
Rosa FE; Caldeira JR; Felipes J; Bertonha FB; Quevedo FC; Domingues MA; Moraes Neto FA; Rogatto SR
Hum Pathol; 2008 May; 39(5):720-30. PubMed ID: 18234277
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.
Rhee J; Han SW; Oh DY; Kim JH; Im SA; Han W; Park IA; Noh DY; Bang YJ; Kim TY
BMC Cancer; 2008 Oct; 8():307. PubMed ID: 18947390
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha, estrogen receptor beta, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma.
Park JS; Jung WH; Kim JK; Hwang HK; Cho SI; Yoon DS; Chi HS; Kim BR
J Surg Res; 2009 Mar; 152(1):104-10. PubMed ID: 18394649
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
[TBL] [Abstract][Full Text] [Related]
18. [The immunohistochemical detection of steroid hormone receptors in breast cancer: open problems and new perspectives].
Barbareschi M; Doglioni C
Pathologica; 2002 Jun; 94(3):115-20. PubMed ID: 12108031
[TBL] [Abstract][Full Text] [Related]
19. The presence of ovarian hormone receptors in the nasal mucosa and their relationship to nasal symptoms.
Philpott CM; Wild DC; Wolstensholme CR; Murty GE
Rhinology; 2008 Sep; 46(3):221-5. PubMed ID: 18853875
[TBL] [Abstract][Full Text] [Related]
20. Insights into the role of progesterone receptors in breast cancer.
Fuqua SA; Cui Y; Lee AV; Osborne CK; Horwitz KB
J Clin Oncol; 2005 Feb; 23(4):931-2; author reply 932-3. PubMed ID: 15681552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
